CLINICAL_TRIALS
trial_result
· 2015-10-15
Clinical Trial Update: Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age [Phase 3]
Summary
Phase 3 clinical trial evaluating the safety and efficacy of aliskiren in children aged 6 to 17 with hypertension; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-10-15